Revolution Medicines Inc RVMD:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
39.41UNCH (UNCH)
Volume
35,254,397
Close
39.41quote price arrow up+0.42 (+1.08%)
Volume
1,118,299
52 week range
15.44 - 40.21
Loading...
  • Open39.38
  • Day High39.80
  • Day Low38.70
  • Prev Close38.99
  • 52 Week High40.21
  • 52 Week High Date05/03/24
  • 52 Week Low15.44
  • 52 Week Low Date10/23/23

Key Stats

  • Market Cap6.502B
  • Shares Out164.99M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.45
  • YTD % Change37.41

KEY STATS

  • Open39.38
  • Day High39.80
  • Day Low38.70
  • Prev Close38.99
  • 52 Week High40.21
  • 52 Week High Date05/03/24
  • 52 Week Low15.44
  • 52 Week Low Date10/23/23
  • Market Cap6.502B
  • Shares Out164.99M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.45
  • YTD % Change37.41

RATIOS/PROFITABILITY

  • EPS (TTM)-3.76
  • P/E (TTM)-10.49
  • Fwd P/E (NTM)-12.64
  • EBITDA (TTM)-546.342M
  • ROE (TTM)-36.17%
  • Revenue (TTM)4.566M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-10,606.04%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Revolution Medicines Inc

 

Profile

MORE
Revolution Medicines, Inc. is a clinical-stage oncology company developing novel targeted therapies for RAS-addicted cancers. The Company’s research and development pipeline comprises RAS(ON) inhibitors that bind directly to RAS variants, which it refers to as RAS(ON) Inhibitors, and RAS companion inhibitors that target key nodes in the RAS pathway or associated pathways, which it refers to as RAS Companion Inhibitors. Its RAS(ON) Inhibitors are designed to be used as...
Mark Goldsmith M.D., Ph.D.
Chairman of the Board, President, Chief Executive Officer
Margaret Horn J.D.
Chief Operating Officer
Jack Anders CPA
Chief Financial Officer
Xiaolin Wang
Executive Vice President - Clinical Development
Address
700 Saginaw Dr
Redwood City, CA
94063-4752
United States

Top Peers

SYMBOLLASTCHG%CHG
CYTK
Cytokinetics Inc
59.53-0.39-0.65%
IBRX
Immunitybio Inc
7.65-0.10-1.29%
PCVX
Vaxcyte Inc
74.57-0.88-1.17%
CERE
Cerevel Therapeutics Holdings Inc
42.10-0.25-0.59%
BBIO
BridgeBio Pharma Inc
30.09-0.95-3.06%